Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resistant Solid Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Not applicableActive Not RecruitingNCT03347318
What this trial is testing

Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease

Who this might be right for
Solid Tumors
Fondazione del Piemonte per l'Oncologia 2,500
Very early researchWithdrawnNCT07052760
What this trial is testing

Imaging of Solid Tumors Using DLL3 SPECT

Who this might be right for
Solid Tumor CancerCastration Resistant Prostate CancerCastration Resistant Prostate Cancer (CRPC)+1 more
Thomas Hope
Testing effectiveness (Phase 2)Study completedNCT00831636
What this trial is testing

A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Clavis Pharma 28
Early research (Phase 1)Ended earlyNCT04244552
What this trial is testing

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+13 more
Atreca, Inc. 87
Early research (Phase 1)Study completedNCT06403436
What this trial is testing

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdult Solid TumorAdult Disease+5 more
TOLREMO therapeutics AG 45
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Testing effectiveness (Phase 2)Study completedNCT05700669
What this trial is testing

Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors

Who this might be right for
Metastatic Castration-resistant Prostate CancerRecurrent Epithelial Ovarian CancerBreast Cancer
Valerio Therapeutics 3
Testing effectiveness (Phase 2)Study completedNCT04564027
What this trial is testing

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Who this might be right for
Advanced Solid Tumours
AstraZeneca 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT03319628
What this trial is testing

First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b

Who this might be right for
Platinum Resistant Ovarian CancerNon Small Cell Lung Cancer Metastatic
Mersana Therapeutics 523
Early research (Phase 1)Study completedNCT02898207
What this trial is testing

Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer

Who this might be right for
Metastatic High Grade Fallopian Tube Serous AdenocarcinomaMetastatic Malignant Solid NeoplasmMetastatic Primary Peritoneal Serous Adenocarcinoma+16 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Ended earlyNCT03729596
What this trial is testing

MGC018 With or Without MGA012 in Advanced Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of Head and NeckTriple Negative Breast CancerMelanoma+3 more
MacroGenics 143
Early research (Phase 1)Study completedNCT01733004
What this trial is testing

MM-141 in Patients With Advanced Solid Tumors

Who this might be right for
Hepatocellular Carcinoma
Merrimack Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT06076135
What this trial is testing

Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmRadiotherapyImmune Checkpoint Blockade+1 more
Chuangzhen Chen 24
Testing effectiveness (Phase 2)Looking for participantsNCT06425926
What this trial is testing

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Who this might be right for
Melanoma Stage IVSolid Tumor
Georgiamune Inc 117
Testing effectiveness (Phase 2)Study completedNCT00004912
What this trial is testing

Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss

Who this might be right for
CachexiaFatigueUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT05272709
What this trial is testing

TT-702 in Patients With Advanced Solid Tumours.

Who this might be right for
Advanced Solid Tumors
Cancer Research UK 60
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Not applicableEnded earlyNCT05891197
What this trial is testing

A Biomarker Screening Protocol for Participants With Solid Tumors

Who this might be right for
Triple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more
Lyell Immunopharma, Inc. 10
Next Page